Scarica l'app Stockscreener
51.04
0.08%
0.04
Dopo l'orario di chiusura:
51.03
-0.010
-0.02%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché HROW Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$51.00
Aprire:
$50.81
Volume 24 ore:
500.59K
Relative Volume:
0.73
Capitalizzazione di mercato:
$1.89B
Reddito:
$154.15M
Utile/perdita netta:
$-33.58M
Rapporto P/E:
-53.17
EPS:
-0.96
Flusso di cassa netto:
$-20.74M
1 W Prestazione:
+4.16%
1M Prestazione:
+7.52%
6M Prestazione:
+64.59%
1 anno Prestazione:
+41.19%
Intervallo 1D:
$49.28
$51.10
Intervallo di 1 settimana:
$46.58
$54.85
Portata 52W:
$20.85
$54.85
Harrow Inc Stock (HROW) Company Profile
Nome
Harrow Inc
Settore
Telefono
615.733.4731
Indirizzo
1A BURTON HILLS BLVD, NASHVILLE, CA
Confronta HROW con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
HROW
Harrow Inc
|
51.04 | 1.89B | 154.15M | -33.58M | -20.74M | -0.96 |
|
ZTS
Zoetis Inc
|
126.85 | 55.38B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
16.37 | 50.23B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
10.04 | 44.75B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
32.51 | 37.17B | 16.88B | 666.71M | 251.19M | 0.6132 |
|
UTHR
United Therapeutics Corp
|
490.83 | 21.69B | 3.08B | 1.24B | 1.07B | 25.61 |
Harrow Inc Stock (HROW) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-11 | Iniziato | Cantor Fitzgerald | Overweight |
| 2025-06-12 | Iniziato | BTIG Research | Buy |
| 2025-06-10 | Iniziato | William Blair | Outperform |
| 2025-02-06 | Iniziato | H.C. Wainwright | Buy |
| 2024-12-04 | Reiterato | B. Riley Securities | Buy |
| 2024-04-11 | Iniziato | Craig Hallum | Buy |
| 2022-09-08 | Ripresa | B. Riley Securities | Buy |
| 2021-10-14 | Ripresa | B. Riley Securities | Buy |
| 2021-09-24 | Iniziato | Aegis Capital | Buy |
| 2021-07-02 | Iniziato | Ladenburg Thalmann | Buy |
Mostra tutto
Harrow Inc Borsa (HROW) Ultime notizie
Is Harrow Inc. stock a good choice for value investorsJuly 2025 Spike Watch & Technical Pattern Recognition Alerts - ulpravda.ru
How Harrow Inc. stock compares to growth peers2025 Short Interest & Accurate Trade Setup Notifications - ulpravda.ru
Major Harrow Health Backer Quietly Unloads a Chunk of Shares - TipRanks
Why Harrow Inc. stock remains a top recommendationMarket Growth Summary & Daily Price Action Insights - ulpravda.ru
Will Harrow Inc. stock deliver shareholder value2025 Key Lessons & Daily Stock Momentum Reports - ulpravda.ru
Harrow Health stock hits 52-week high at 54.85 USD - Investing.com
Harrow Health stock hits 52-week high at 54.85 USD By Investing.com - Investing.com India
Harrow, Inc. (HROW) Stock Analysis: Navigating a 28.88% Upside Potential Amidst Robust Revenue Growth - DirectorsTalk Interviews
Harrow (NASDAQ:HROW) Hits New 12-Month HighWhat's Next? - MarketBeat
Harrow Health Builds Focused Ophthalmic Care Platforms - Kalkine Media
HARROW INC (NASDAQ:HROW) Emerges as a High-Growth Momentum Stock with Strong Technical Setup - Chartmill
Calamos Advisors LLC Makes New $1.09 Million Investment in Harrow, Inc. $HROW - MarketBeat
Harrow (NASDAQ:HROW) Hits New 1-Year HighTime to Buy? - MarketBeat
Harrow Health stock hits 52-week high at 51.38 USD - Investing.com
Harrow Health stock hits 52-week high at 51.38 USD By Investing.com - Investing.com UK
Harrow, Inc. (NASDAQ:HROW) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Brookstone Capital Management Grows Stock Holdings in Harrow, Inc. $HROW - MarketBeat
Harrow, Inc. $HROW Shares Sold by Rice Hall James & Associates LLC - MarketBeat
Harrow (NASDAQ:HROW) Has A Somewhat Strained Balance Sheet - 富途牛牛
Squarepoint Ops LLC Has $640,000 Stock Holdings in Harrow, Inc. $HROW - MarketBeat
First Week of February 2026 Options Trading For Harrow (HROW) - Nasdaq
Is Harrow Inc. stock vulnerable to regulatory risksJuly 2025 PreEarnings & Daily Technical Stock Forecast Reports - bolumsonucanavari.com
Will Harrow Inc. stock gain from strong economyAnalyst Downgrade & Stepwise Trade Signal Guides - Улправда
What margin trends mean for Harrow Inc. stockQuarterly Portfolio Summary & Long-Term Capital Growth Strategies - DonanımHaber
Why Harrow Inc. stock appeals to dividend seekersJuly 2025 Intraday Action & Real-Time Volume Trigger Notifications - Улправда
Insider Buy: Can Harrow Inc. stock resist market sell offsRate Hike & Free Accurate Trade Setup Notifications - ulpravda.ru
Is Harrow Inc. stock attractive for income investorsMarket Performance Report & Consistent Growth Equity Picks - Улправда
CFO Boll Acquires 33,335 Of Harrow Inc [HROW] - TradingView — Track All Markets
Harrow (HROW) CEO Mark Baum exercises 180,000 stock options in company - Stock Titan
Harrow (NASDAQ:HROW) Trading Down 5.8%Should You Sell? - MarketBeat
Braidwell LP Trims Holdings in Harrow, Inc. $HROW - MarketBeat
Harrow (NASDAQ:HROW) Reaches New 52-Week HighWhat's Next? - MarketBeat
Harrow Health stock hits 52-week high at 50.75 USD - Investing.com
Harrow, Inc. $HROW Shares Bought by Marshall Wace LLP - MarketBeat
Precision Trading with Harrow Health Inc. 11.875% Senior Notes Due 2027 (HROWM) Risk Zones - Stock Traders Daily
Divisadero Street Capital Management LP Takes Position in Harrow, Inc. $HROW - MarketBeat
Aug Closing: Why Harrow Inc stock is favored by pension funds2025 Performance Recap & Daily Entry Point Trade Alerts - moha.gov.vn
Harrow (HROW) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
How the Narrative Surrounding Harrow Is Evolving After Analyst Target Upgrades - Yahoo Finance
Can Harrow Inc. stock deliver strong Q4 earningsLong Setup & Safe Capital Growth Stock Tips - Newser
Panagora Asset Management Inc. Acquires Shares of 47,132 Harrow, Inc. $HROW - MarketBeat
155,465 Shares in Harrow, Inc. $HROW Acquired by Diametric Capital LP - MarketBeat
Harrow (NASDAQ:HROW) Shares Up 10.2%Time to Buy? - MarketBeat
How CVS Elevating Vevye To Tier 1 Coverage At Harrow (HROW) Has Changed Its Investment Story - Yahoo Finance
Should Vevye’s CVS Formulary Win Prompt a Closer Look from Harrow (HROW) Investors? - simplywall.st
Harrow: Vevye Replaces Xiidra On Tier 1 Formulary At CVS (NASDAQ:HROW) - Seeking Alpha
Creative Planning Grows Holdings in Harrow, Inc. $HROW - MarketBeat
Harrow, Inc. $HROW Shares Purchased by Geode Capital Management LLC - MarketBeat
Intech Investment Management LLC Sells 6,798 Shares of Harrow, Inc. $HROW - MarketBeat
Insider Sell: Why Harrow Inc. stock appeals to dividend seekersMarket Trend Review & Weekly High Return Stock Opportunities - moha.gov.vn
Market Trends: Is Harrow Inc. stock attractive for income investors - moha.gov.vn
Harrow Inc Azioni (HROW) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.41%
1.75%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):